A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren

Tuberculosis (TB) is a serious infectious disease caused by a bacterial pathogen. Mortality from tuberculosis was estimated at 1.5 million deaths worldwide in 2013. Development of new TB drugs is needed to not only to shorten the medication period but also to treat multi-drug resistant and extensive...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS One
Κύριοι συγγραφείς: Ozeki, Yuriko, Igarashi, Masayuki, Doe, Matsumi, Tamaru, Aki, Kinoshita, Naoko, Ogura, Yoshitoshi, Iwamoto, Tomotada, Sawa, Ryuichi, Umekita, Maya, Enany, Shymaa, Nishiuchi, Yukiko, Osada-Oka, Mayuko, Hayashi, Tetsuya, Niki, Mamiko, Tateishi, Yoshitaka, Hatano, Masaki, Matsumoto, Sohkichi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2015
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4646695/
https://ncbi.nlm.nih.gov/pubmed/26571296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141658
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια